Indian drugmakers face squeeze in U.S. healthcare market
India's small and medium-sized generic drugmakers say the threat of
tougher rules and higher barriers for outsiders in the U.S. healthcare
market will force many to find a niche or focus their expansion efforts
on other countries.
India supplies nearly a third of medicines sold in the United States,
the world's largest healthcare market. Cut-price generics sold by
India's small- and medium-sized drugmakers have been critical in
bringing down prices there.
A more protectionist stance by President Donald Trump, with the
prospect of import tariffs and the U.S. boosting local drug
manufacturing, mean the operating environment for smaller generic
players will get worse, executives at Indian companies said.
Get Live Indian Stock Market News Updates Visit Us www.marketmagnify.com or Get Free Trials Just Give One Missed Call @7879-881-122.
No comments:
Post a Comment